Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: a cross-sectional study
Treatment outcomes for nasopharyngeal carcinoma (NPC) have improved significantly over the past few decades. With the advances in radiotherapy techniques and systemic chemotherapy,5-year survival rates as high as 70 – 85% are expected forpatients with loco-regionally advanced diseases.[1] Although the advent of modern intensity-modulated radiotherapy (IMRT) techniques has greatly improved tumor target conformity, radiation that traverses normal tissue continues to bring along late complications that greatly i mpair the quality of life of long-term survivors.
Source: Radiotherapy and Oncology - Category: Radiology Authors: James C.H. Chow, Jack Lee, Maria M.P. Lai, Sara Li, Adelina M.C. Lau, Beni S.Y. Ng, Gigi G.G. Leung, Sharon T.Y. Li, Jeffrey C.F. Lui, K.M. Cheung, K.H. Au, K.H. Wong, Alexander Y.L. Lau, Benny C.Y Zee Tags: Original Article Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Intensity-Modulated Radiation Therapy | Nasopharyngeal Cancer | Neurology | Radiology | Study